Back to results
US 2026/0258388 A1Published application
Compositions and methods for targeted ides treatment of igg-related disorders
AssigneeThe Regents of the University of Michigan
InventorsBenjamin TOURDOT, Peter TESSIER, Colin GREINEDER
Life of this patent
Estimating the term…
Abstract
Provided herein are fusions comprising targeted immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) and methods of treating/preventing pathogenic IgG-related disorders therewith.
Claims82
A composition comprising an immunoglobulin-G degrading enzyme fused to a targeting moiety capable of specifically binding to a cell surface marker.
Dependencies are inferred from the claim text.